Neurologists debate the data on familiar immunosuppressive agents.
Randy Dotinga is an indie scribbler and writer advocate, known for his work in the field of medicine and healthcare. He has written for various publications, including MDEdge, Medscape, MedPage Today, and The Washington Post, covering topics such as eye diseases, medical research, and healthcare guidelines. Randy's articles provide insights into the latest developments in the medical field and aim to inform and educate readers.